Your session is about to expire
← Back to Search
Behavioural Intervention
Dietary Intervention for Melanoma
Phase 1
Recruiting
Led By Jennifer McQuade
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
Study Summary
This trial is studying the effects of two different diets on patients with a history of melanoma. One diet is rich in whole foods and fiber, while the other is a ketogenic diet. Participants will be provided all food for the six-week study, but will need to come in for initial screening and blood tests every two weeks.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility of conducting a controlled feeding study in melanoma patients
Trial Design
2Treatment groups
Experimental Treatment
Group I: Group II (ketogenic diet)Experimental Treatment2 Interventions
Patients consume a high fat, low carbohydrate (ketogenic) diet for 6 weeks.
Group II: Group I (fiber-rich diet)Experimental Treatment2 Interventions
Patients consume a whole-foods, fiber-rich diet for 6 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dietary Intervention
2014
Completed Phase 2
~2550
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,967 Previous Clinical Trials
1,804,782 Total Patients Enrolled
102 Trials studying Melanoma
25,315 Patients Enrolled for Melanoma
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,647 Total Patients Enrolled
557 Trials studying Melanoma
193,213 Patients Enrolled for Melanoma
Jennifer McQuadePrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
42 Total Patients Enrolled
1 Trials studying Melanoma
42 Patients Enrolled for Melanoma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have taken antibiotics in the last month, as confirmed by you or your doctor.You have received treatment for melanoma in the past year.You have significant dietary restrictions that relate to the study treatment.You have been diagnosed with type I or type II diabetes and need medicine to treat it.Your body mass index (BMI) is between 18.5 and 40.Your creatinine level in the blood is less than 1.5 mg/dL.Your liver function tests show levels that are two times higher than normal.Your blood sugar level when you haven't eaten should be less than 125 mg/dL.You are currently on a very high-fat diet, consuming a lot of fiber every day, or following a vegetarian or vegan diet.Women who could become pregnant must have a negative pregnancy test within one week before the DEXA scan.You smoke, drink heavily (more than 14 drinks per week), or use illegal drugs.You have been taking certain supplements or medications for weight loss or bodybuilding in the last 30 days.Your LDL cholesterol level is higher than 200 mg/dL within the last 28 days.Your triglyceride levels are higher than 350 mg/dL within the past 28 days.You had melanoma removed within the last 5 years and currently don't have any signs of the disease.
Research Study Groups:
This trial has the following groups:- Group 1: Group I (fiber-rich diet)
- Group 2: Group II (ketogenic diet)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger